Fatigue from immunotherapy in lung cancer: a patient interview study
Part of Cancer, Lungs & breathing clinical trials.
This study aims to understand how maintenance immunotherapy affects fatigue in people with non-small cell lung cancer. Researchers will talk with patients to learn about their experiences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You can speak, read, and understand English
- You have non-small cell lung cancer and are on immunotherapy alone (no chemotherapy in the last 3 months)
- You have had at least 2 cycles of immunotherapy and plan to continue for at least 3 more months
- You have cancer-related fatigue that affects your daily life
- You do not have dementia, untreated thyroid issues, symptomatic heart failure, or oxygen-dependent lung disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and analyzes medical information (and sometimes tissue samples) to help personalize treatment plans for advanced non-small-cell lung cancer using immunotherapy. It may help researchers find which people benefit most and how treatment can be better matched to each patient.
This trial tests whether giving immunotherapy again can help people with advanced non-small cell lung cancer whose disease stayed stable for at least 2 years on their first immunotherapy but then started growing. It aims to see if a second course of treatment can work again.
This study asks cancer survivors about their fatigue (tiredness, weakness, or exhaustion) to better understand it. It involves filling out questionnaires and maybe an interview. Your participation helps doctors learn how to support survivors like you.
This study looks at fatigue in Chinese cancer patients to understand how common it is and how it affects their health. You may join if you have a confirmed cancer diagnosis and are at least 18 years old.
This study aims to understand the care needs of people with lung cancer who are receiving or have received immunotherapy. By participating, you can help improve support for other patients going through similar treatment.
This study is a survey to learn about the experiences and feelings of people with non-small cell lung cancer who are taking immunotherapy drugs. The goal is to understand how you're doing on treatment, which can help improve care for others.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.